正常血钙型原发性甲状旁腺功能亢进的手术治疗安全有效
该回顾性队列纳入2000至2023年接受甲状旁腺切除术的554例正常血钙型原发性甲状旁腺功能亢进患者,89%有临床表现,58%为多腺体病变。术中甲状旁腺激素下降>50%者占99%,6个月时甲状旁腺激素正常者占81%,严重并发症罕见;18例前瞻性生活质量试点研究中,术后2周中位总体生活质量评分从29显著改善至2(P<.001)。
要点
- 正常血钙型原发性甲状旁腺功能亢进患者中89%有临床表现,58%为多腺体病变。
- 术中甲状旁腺激素下降>50%者占99%,6个月时甲状旁腺激素正常者占81%。
- 18例试点研究显示术后2周总体及各个维度生活质量均显著改善。
核心结论
- 正常血钙型原发性甲状旁腺功能亢进的手术治疗安全有效,并在前瞻性试点研究中与术后2周生活质量显著改善相关。
研究设计与样本
- 回顾性审查前瞻性维护数据库,纳入2000至2023年接受甲状旁腺切除术的正常血钙型原发性甲状旁腺功能亢进患者554例。
- 其中一小部分患者(n=18)参与前瞻性生活质量试点研究。
主要发现
- 554例患者中89%有临床表现,58%由多腺体病变引起。
- 术中甲状旁腺激素下降>50%者占99%,6个月时甲状旁腺激素水平正常者占81%。
- 严重并发症罕见;年轻患者术后暂时性低钙血症发生率更高(P<.01)。
- 接受双侧探查的患者中黑人比例更高(P<.01)。
- 参与生活质量研究的18例患者中,中位总体生活质量评分从术前29(四分位距18)改善至术后2周2(四分位距18)(P<.001)。
临床怎么用
- 对于正常血钙型原发性甲状旁腺功能亢进患者,甲状旁腺切除术可作为安全管理选项,并可能改善生活质量。
局限性
- 生活质量改善证据来自小样本(n=18)前瞻性试点研究。
- 研究为回顾性设计,证据等级有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The ideal management of normocalcemic primary hyperparathyroidism is controversial and is not discussed in recent guidelines as a result of limited published data. To help fill this knowledge gap, we aimed to report the outcomes of a large case series of patients with normocalcemic primary hyperparathyroidism who underwent parathyroidectomy. METHODS: A retrospective review of a prospectively maintained database was conducted to identify patients with normocalcemic primary hyperparathyroidism who underwent parathyroidectomy from 2000 to 2023. A small subset of patients participated in a prospective quality of life pilot study. RESULTS: In 554 patients with normocalcemic primary hyperparathyroidism who underwent parathyroidectomy, 89% had clinical manifestations and 58% were caused by multigland disease. Intraoperative parathyroid hormone decrease >50% was achieved in 99% and normal parathyroid hormone levels at 6 months were achieved in 81% of patients. Serious complications were rare. Younger patients had greater rates of transient postoperative hypocalcemia (P < .01). Patients undergoing bilateral exploration were more likely to be Black (P < .01). In participating patients (n = 18), median overall quality of life improved significantly from 29 (interquartile range, 18) preoperatively to 2 (interquartile range, 18) at 2 weeks' postoperatively (P < .001). Each of the individual quality of life subsections including the pain, activities of daily living, occupation, mobility, leisure, general health, and mental function domains all improved significantly after parathyroidectomy (P < .05). CONCLUSION: We have herein reported the largest institutional case series of patients with normocalcemic primary hyperparathyroidism undergoing parathyroidectomy. Surgery for normocalcemic primary hyperparathyroidism was safe, effective, and, in a prospective pilot study, was associated with significant improvements in quality of life at 2 weeks postoperatively. These findings further support that parathyroidectomy may play an important role in the management of normocalcemic primary hyperparathyroidism.
引用
- Frye CC, Song Z, Balachandra S, et al. Surgery for normocalcemic hyperparathyroidism is safe and effective. Surgery. 2025. PMID: 41015676. doi:10.1016/j.surg.2025.109707
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。